Clinical Trials Directory

Trials / Completed

CompletedNCT05336110

Impact of the Postponement of Surgery on Postoperative Morbidity After Sars-cov-2 Infection

Assessment of the Impact of the Postponement of Surgery on the Postoperative Morbidity After Sars-cov-2 Infection in 2022

Status
Completed
Phase
Study type
Observational
Enrollment
5,189 (actual)
Sponsor
Société Française d'Anesthésie et de Réanimation · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The deployment of vaccination against SARS-CoV-2 from 2021 led to a modification in June 2021of previous recommendations concerning the postponing scheduled surgery suggesting local adaptations of this delay if epidemic developments appear. Today, the evolutions of the pandemic make these recommendations obsolete and impose the updating of the data produced during the first epidemic wave of 2020. Among these evolutions, the two most important are the existence of a large vaccination coverage on the one hand and the emergence of variants of lesser severity on the other hand

Detailed description

Previous studies performed during the first COVID-19 epidemic wave in the first half of 2020 led to the recommendation, after taking into account the individual risk-benefit balance, of postponing scheduled surgery for ideally at least 6 completed weeks in a patient with a positive preoperative SARS-CoV-2 PCR. The deployment of vaccination against SARS-CoV-2 from 2021 led to a modification of these recommendations in June 2021 suggesting local adaptations of this delay if epidemic developments appear. Today, the evolutions of the pandemic make these recommendations obsolete and impose the updating of the data produced during the first epidemic wave of 2020. Among these evolutions, the two most important are the existence of a large vaccination coverage on the one hand and the emergence of variants of lesser severity on the other hand

Conditions

Interventions

TypeNameDescription
OTHERPostponing surgeryPostponing surgery for patients with Sars-cov-2 infection

Timeline

Start date
2022-03-14
Primary completion
2022-05-13
Completion
2022-05-13
First posted
2022-04-20
Last updated
2022-07-18

Locations

40 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05336110. Inclusion in this directory is not an endorsement.